L3Harris Is Sitting on a $40.7 Billion Backlog and the Market Still Won't Say Thank You
⚠️ Not financial advice. This post is for informational and educational purposes only. Forecasts and commentary are model outputs and opinions, may be inaccurate, and are not a recommendation to buy or sell any security or asset. Do your own research. AI-assisted: this article was drafted with AI and reviewed by a human before publishing.
# L3Harris Is Sitting on a $40.7 Billion Backlog and the Market Still Won't Say Thank You
Here's a fun exercise: find me another defense prime that just booked $7.8 billion in quarterly orders, pushed its backlog to a record $40.7 billion, grew organic revenue 15%, and got rewarded with a stock that's down nearly 24% from its 52-week high. L3Harris (LHX) is that company, trading at $288.69 against a March peak of $379.23, and the disconnect between the fundamentals and the price action is the whole story right now.
Let's start with what's actually working. Q1 2026 wasn't a "beat and raise on accounting fumes" quarter — it was orders of $7.8 billion against revenue of $5.7 billion, a book-to-bill of 1.4x, and GAAP diluted EPS up 33% to $2.72. That's not a company squeezing margin out of a shrinking pie; that's a company whose customers keep showing up with checkbooks. And the checkbooks keep coming: on July 1, the FAA handed L3Harris a contract to modernize and operate the national aircraft-tracking network — 700-plus ground stations — through 2045. Twenty years of annuity-like cash flow. Then, on July 13, the Space Development Agency awarded L3Harris 18 satellites for the Golden Dome missile-defense architecture. Contract value undisclosed, sure, but the signal is loud: this is direct validation of the Space & Mission Systems segment and the exact secular thesis bulls have been pitching for two years.
Layer on the Arkansas facility expansion for PAC-3 propulsion — more interceptor motors for NATO and the U.S. — and a Pentagon-backed plan to spin the Missile Solutions business into an IPO in the back half of 2026 with a $1 billion capital commitment behind it, and you've got a company actively de-risking and diversifying its backlog at the exact moment the market has decided to look away.
So why the stock chart? Two honest reasons, and I'll give the bears their due.
One: the cash flow doesn't match the narrative — yet. Q1 swung to a negative $194 million in free cash flow and negative $95 million operating cash flow, with working capital collapsing from $1.37 billion to $293 million and cash dropping from $1.07 billion to $590 million in a single quarter. That's the kind of number that makes a portfolio manager squint, even if it's plausibly just backlog-driven working-capital timing ahead of production ramps. Gross margin also compressed to 24.4% from ~26% the prior two quarters — thin cushion for a company still carrying $11.4 billion in total debt.
Two: L3Harris has simply lost the relative-strength contest. Lockheed Martin is up 7.5% year-to-date while LHX has been sliding since its spring peak — lower highs from ~$375 in March down through the ~$300 zone by June. Technically, the stock is sitting below its 20-, 50-, and 200-day averages, with RSI at 41 — weak, not oversold, not screaming capitulation either. Support lives at $285–289 (defended repeatedly in recent weeks) with the 52-week low at $257.35 lurking below that. Resistance stacks up at $295, then $300–303, then $310–317, and the stock needs to reclaim $310 before anyone should call the downtrend over.
Here's my actual take: this is not a broken company, it's a mispriced one, and the mispricing has a catalyst date. July 29 earnings is the whole ballgame. At a 21.1x forward multiple against 13.7% projected five-year EPS growth — and Street numbers already pointing to $11.52 in FY26 EPS growing 17.4% to $13.52 in FY27 — this is not an expensive stock for what it's booking in backlog. It's a stock waiting for cash flow to catch up to orders, and for the market to stop pricing it like Lockheed's slower cousin.
I wouldn't chase it above $310 before earnings, and I wouldn't be a hero buying the last dollar of weakness into $285. But treating this pullback as a reason to avoid the name — rather than a reason to build a position into a print with a genuinely favorable setup — misses the point entirely. The backlog doesn't lie. The stock chart, for now, just hasn't caught up to it.
More on LHX
Market commentary from the K3vl4r desk — not personalized investment advice. More posts →